论文部分内容阅读
目的探索欣普贝生用于足月引产产妇中的临床效果。方法 100例足月引产产妇,依据动态随机化分为观察组和对照组,各50例。对照组采用常规催产素治疗,观察组采用欣普贝生治疗。对比两组治疗效果。结果治疗后,观察组产妇出血量为(154.36±8.95)ml,临产时间为(10.25±2.98)h。对照组产妇出血量为(243.69±9.54)ml,临产时间为(18.69±4.75)h。观察组产妇的出血量、临产时间显著优于对照组,差异均具有统计学意义(P<0.05)。观察组新生儿窒息率、引产成功率、不良反应发生率显著优于对照组,差异均具有统计学意义(P<0.05)。结论欣普贝生用于足月引产产妇中效果显著,其可有效提高产妇引产成功率,值得临床广泛使用。
Objective To explore the clinical effect of Hinbebex in full-term induced labor. Methods 100 cases of full-term induced labor were divided into observation group and control group according to dynamic randomization, 50 cases each. The control group was treated with conventional oxytocin, and the observation group was treated with dexpabone. Compare the two groups treatment effect. Results After treatment, the amount of maternal bleeding in the observation group was (154.36 ± 8.95) ml and the duration of labor was (10.25 ± 2.98) h. The amount of bleeding in the control group was (243.69 ± 9.54) ml and the labor time was (18.69 ± 4.75) h. The observation group maternal blood loss, labor time was significantly better than the control group, the differences were statistically significant (P <0.05). The observation group neonatal asphyxia, induction of labor success rate, the incidence of adverse reactions was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion The effect of Hinbu Beisin on full-term induced labor is significant. It can effectively improve the success rate of induced labor and deserves to be widely used clinically.